Market Tracker

10/30 7:05pm ET

Actavis PLC (NYSE:ACT)

243.21
Data as of Oct 30
 +4.43 / +1.86%
Today’s Change
153.42
Today|||52-Week Range
249.94
+44.77%
Year-to-Date

Today’s Trading

Previous close238.78
Today’s open238.36
Day’s range236.00 - 245.00
Volume1,743,003
Average volume (3 months)2,408,914
Market cap$63.1B
Dividend yield--
Data as of 4:04pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+40.02%
Earnings growth (next 5 years)+18.41%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.36

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.75+1.75%
AGNAllergan Inc+2.67+1.43%
LLYEli Lilly and Co+1.31+2.00%
VRXValeant Pharmaceutic...+1.75+1.35%
Data as of 4:07pm ET, 10/30/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$3.11
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts